3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
26
Small Cell Lung Carcinoma
22
Neuroblastoma
12
Fallopian Tube Neoplasms
12
Uterine Cervical Neoplasms
8
Carcinoma, Ovarian Epithelial
8
Lung Neoplasms
7
Neoplasm Metastasis
5
Carcinoma, Non-Small-Cell Lung
4
Leukemia, Myeloid, Acute
3
Ganglioneuroblastoma
3
Brain Neoplasms
3
Sarcoma
2
Recurrence
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neoplasms
2
Hereditary Sensory and Autonomic Neuropathies
2
Gliosarcoma
2
Glioblastoma
2
Central Nervous System Neoplasms
2
Carcinoma, Small Cell
2
Carcinoma, Neuroendocrine
2
Thrombocythemia, Essential
1
Sarcoma, Ewing
1
Rhabdoid Tumor
1
Retinoblastoma
1
Retinal Neoplasms
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Interventions
Bevacizumab
3
ribociclib
2
Temozolomide
2
Radiotherapy
2
Radiation
2
Panobinostat
2
pembrolizumab
1
dipinacoline glutamate
1
dinutuximab
1
cemiplimab
1
adavosertib
1
abemaciclib
1
Vorinostat
1
Valproic Acid
1
Re-Irradiation
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Nivolumab
1
Maintenance
1
Irinotecan
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Everolimus
1
Erlotinib Hydrochloride
1
Congresses as Topic
1
Chemotherapy, Adjuvant
1
Cetuximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Diffuse Intrinsic Pontine Glioma
×
Topotecan
×
Clear all
No trials found.